Stephen C. Glover - Feb 28, 2025 Form 4 Insider Report for PDS Biotechnology Corp (PDSB)

Role
Director
Signature
/s/ Spencer Brown, as Attorney-in-Fact
Stock symbol
PDSB
Transactions as of
Feb 28, 2025
Transactions value $
$25,001
Form type
4
Date filed
3/3/2025, 04:45 PM
Previous filing
Jun 25, 2024
Next filing
Jun 11, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PDSB Common Stock Purchase $25K +15.1K +23.61% $1.66 78.9K Feb 28, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PDSB Common Warrant Purchase +15.1K 15.1K Feb 28, 2025 Common Stock 15.1K $1.53 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchase price for the Common Warrant is included in the purchase price for the shares of Common Stock reflected in Table I above.